Advertisement

Organisation › Details
CovalX (Group)
CovalX is the market leader in intact protein complex analysis using high mass MALDI based technology with headquarters in Zürich, Switzerland and a North American subsidiary in Saugus, MA. CovalX also supports sales/distribution across Europe, in Japan, Korea and Russia. The technology and applications are protected by a strong patent portfolio. Target groups consist primarily of life science research laboratories and pharmaceutical and biotechnology companies worldwide. CovalX focuses on biotech analytics as the prime area for future growth. The company currently has released its third generation of high mass MALDI detection systems on the market with a range of stabilization chemistries and data analysis software for applications characterizing protein interactions. CovalX also offers a full CRO analytics service featuring all of its novel applications directly to customer. Based in Zürich, Switzerland, the company is privately held. *
![]() |
Start | 2005-01-01 established |
![]() |
Industry | MALDI-TOF mass spectrometry technology |
Industry 2 | mass spectrometry services (MS services) | |
![]() |
Region | Schlieren ZH |
Country | Switzerland | |
Street | 11a Grabenstr. | |
City | 8952 Schlieren ZH | |
Tel | +41-755-7000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-12-29 |
Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top